| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9951208 | European Journal of Vascular and Endovascular Surgery | 2005 | 13 Pages |
Abstract
A fixed daily dose of tinzaparin for 6 months was at least as effective and safe as UFH and acenocoumarol. Regarding major events and recanalization, there was a significant benefit in favor of tinzaparin. Long-term DVT treatment with tinzaparin could represent an alternative to conventional treatment.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
M.E. Daskalopoulos, S.S. Daskalopoulou, E. Tzortzis, P. Sfiridis, A. Nikolaou, D. Dimitroulis, I. Kakissis, C.D. Liapis,